Steven Cohen Novartis Ag Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Novartis Ag stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,082,375 shares of NVS stock, worth $121 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

1,082,375

Previous 30,800 3414.2%

Holding current value

$121 Million

Previous $3 Million 3926.13%

% of portfolio

0.3%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$97.14 - $115.57 $105 Million - $125 Million	1,082,375 New	1,082,375 $121 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $68.7 Million - $76.2 Million	-725,039 Reduced 80.0%	181,247 $18.5 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $83.7 Million - $94.9 Million	-905,061 Reduced 49.97%	906,286 $91.5 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $88.5 Million - $103 Million	1,105,547 Added 156.64%	1,811,347 $167 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $4.24 Million - $5.19 Million	56,100 Added 8.63%	705,800 $64 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $26 Million - $30.4 Million	348,500 Added 115.7%	649,700 $49.4 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $24.3 Million - $28.2 Million	301,200 New	301,200 $25.5 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $12.2 Million - $13.9 Million	-152,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $12.2 Million - $13.5 Million	152,900 New	152,900 $13.4 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $62.1 Million - $75.1 Million	-794,930 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $65.3 Million - $72.3 Million	794,930 New	794,930 $69.1 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $45.7 Million - $51.6 Million	-541,255 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$85.54 - $94.26 $23.5 Million - $25.9 Million	274,355 Added 102.79%	541,255 $47 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $87.8 Million - $108 Million	-1,164,797 Reduced 81.36%	266,900 $24.4 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $8.99 Million - $10.3 Million	-119,374 Reduced 7.7%	1,431,697 $138 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $39.2 Million - $43.7 Million	532,803 Added 52.32%	1,551,071 $133 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $68.2 Million - $78.8 Million	1,018,268 New	1,018,268 $87.7 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $30.1 Million - $34 Million	-463,786 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $28.1 Million - $33.5 Million	398,595 Added 611.43%	463,786 $37.5 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $4.72 Million - $5.06 Million	65,191	65,191 $5.47 Million

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account